| Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease A Beilina, IN Rudenko, A Kaganovich, L Civiero, H Chau, SK Kalia, ... Proceedings of the National Academy of Sciences 111 (7), 2626-2631, 2014 | 382 | 2014 |
| Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells L Iovino, ME Tremblay, L Civiero Journal of pharmacological sciences 144 (3), 151-164, 2020 | 233 | 2020 |
| GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2 A Biosa, A Trancikova, L Civiero, L Glauser, L Bubacco, E Greggio, ... Human molecular genetics 22 (6), 1140-1156, 2013 | 167 | 2013 |
| Glial phagocytic clearance in Parkinson’s disease ME Tremblay, MR Cookson, L Civiero Molecular neurodegeneration 14 (1), 16, 2019 | 122 | 2019 |
| Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers L Civiero, R Vancraenenbroeck, E Belluzzi, A Beilina, E Lobbestael, ... Public Library of Science 7 (8), e43472, 2012 | 117 | 2012 |
| LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate E Belluzzi, A Gonnelli, MD Cirnaru, A Marte, N Plotegher, I Russo, ... Molecular neurodegeneration 11, 1-16, 2016 | 102 | 2016 |
| Analysis of the catecholaminergic phenotype in human SH-SY5Y and BE (2)-M17 neuroblastoma cell lines upon differentiation R Filograna, L Civiero, V Ferrari, G Codolo, E Greggio, L Bubacco, ... PLoS one 10 (8), e0136769, 2015 | 88 | 2015 |
| Differential protein–protein interactions of LRRK 1 and LRRK 2 indicate roles in distinct cellular signaling pathways L Reyniers, MG Del Giudice, L Civiero, E Belluzzi, E Lobbestael, A Beilina, ... Journal of neurochemistry 131 (2), 239-250, 2014 | 88 | 2014 |
| Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation E Lobbestael, L Civiero, T De Wit, JM Taymans, E Greggio, V Baekelandt Scientific reports 6 (1), 33897, 2016 | 82 | 2016 |
| RAB8, RAB10 and RILPL1 contribute to both LRRK2 kinase–mediated centrosomal cohesion and ciliogenesis deficits AJ Lara Ordónez, B Fernández, E Fdez, M Romo-Lozano, ... Human molecular genetics 28 (21), 3552-3568, 2019 | 76 | 2019 |
| BEL β-trefoil: A novel lectin with antineoplastic properties in king bolete (Boletus edulis) mushrooms M Bovi, L Cenci, M Perduca, S Capaldi, ME Carrizo, L Civiero, ... Glycobiology 23 (5), 578-592, 2013 | 75 | 2013 |
| Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease? E Greggio, M Bisaglia, L Civiero, L Bubacco Molecular neurodegeneration 6, 1-10, 2011 | 75 | 2011 |
| Parkinson’s disease–associated LRRK2 interferes with astrocyte-mediated alpha-synuclein clearance L Streubel-Gallasch, V Giusti, M Sandre, I Tessari, N Plotegher, E Giusto, ... Molecular Neurobiology 58, 3119-3140, 2021 | 74 | 2021 |
| Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brain L Civiero, MD Cirnaru, A Beilina, U Rodella, I Russo, E Belluzzi, ... Journal of neurochemistry 135 (6), 1242-1256, 2015 | 74 | 2015 |
| LRRK2 deficiency impacts ceramide metabolism in brain R Ferrazza, S Cogo, H Melrose, L Bubacco, E Greggio, G Guella, ... Biochemical and biophysical research communications 478 (3), 1141-1146, 2016 | 64 | 2016 |
| PAK6 phosphorylates 14-3-3γ to regulate steady state phosphorylation of LRRK2 L Civiero, S Cogo, A Kiekens, C Morganti, I Tessari, E Lobbestael, ... Frontiers in molecular neuroscience 10, 417, 2017 | 61 | 2017 |
| Ceramides in Parkinson’s disease: from recent evidence to new hypotheses N Plotegher, L Bubacco, E Greggio, L Civiero Frontiers in Neuroscience 13, 446335, 2019 | 56 | 2019 |
| PAKs in the brain: Function and dysfunction L Civiero, E Greggio Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (2), 444-453, 2018 | 47 | 2018 |
| Parkinson’s disease and immune system: is the culprit LRRKing in the periphery? E Greggio, L Civiero, M Bisaglia, L Bubacco Journal of Neuroinflammation 9, 1-7, 2012 | 47 | 2012 |
| The LRRK2 variant E193K prevents mitochondrial fission upon MPP+ treatment by altering LRRK2 binding to DRP1 M Perez Carrion, F Pischedda, A Biosa, I Russo, L Straniero, L Civiero, ... Frontiers in molecular neuroscience 11, 64, 2018 | 43 | 2018 |
Elisa GreggioAssociate Professor of Physiology在 unipd.it 的电子邮件经过验证
